Correlation Between Inozyme Pharma and Dyadic International
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Dyadic International at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Dyadic International into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Dyadic International, you can compare the effects of market volatilities on Inozyme Pharma and Dyadic International and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Dyadic International. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Dyadic International.
Diversification Opportunities for Inozyme Pharma and Dyadic International
-0.73 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Inozyme and Dyadic is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Dyadic International in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dyadic International and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Dyadic International. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dyadic International has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Dyadic International go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Dyadic International
Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Dyadic International. But the stock apears to be less risky and, when comparing its historical volatility, Inozyme Pharma is 1.15 times less risky than Dyadic International. The stock trades about 0.0 of its potential returns per unit of risk. The Dyadic International is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 181.00 in Dyadic International on September 15, 2024 and sell it today you would lose (18.00) from holding Dyadic International or give up 9.94% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inozyme Pharma vs. Dyadic International
Performance |
| Timeline |
| Inozyme Pharma |
| Dyadic International |
Inozyme Pharma and Dyadic International Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and Dyadic International
The main advantage of trading using opposite Inozyme Pharma and Dyadic International positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Dyadic International can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyadic International will offset losses from the drop in Dyadic International's long position.| Inozyme Pharma vs. Puma Biotechnology | Inozyme Pharma vs. Iovance Biotherapeutics | Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. Zentalis Pharmaceuticals Llc |
| Dyadic International vs. Puma Biotechnology | Dyadic International vs. Iovance Biotherapeutics | Dyadic International vs. Day One Biopharmaceuticals | Dyadic International vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |